Original Article

VOLUME: 40 | ISSUE: 1 | Mar 15, 2024 | PAGE: (32 - 36) | DOI: 10.24911/BioMedica/5-1148

Is Mucormycosis an Addition to the Pandemic Spectrum: An Observational Study


Authors: Muhammad Ilyas , Ghulam Dastgir Khan , Ghazala Rubi , Hurtamina Khan , Adeel Niaz , Waqas Javaid ,


Authors

Muhammad Ilyas

Assoc Professor and Head, Dept of ENT Unit-II, Ameer ud Din Medical College, Postgraduate Medical Institute, Lahore, Pakistan.

Ghulam Dastgir Khan

Associate Professor, Department of ENT, Sharif Medical College, Lahore, Pakistan.

Ghazala Rubi

Director Research Lab & Head of Molecular Genetics Pathology at Post Graduate Medical Institute, Lahore, Pakistan.

Hurtamina Khan

Associate Professor, Department of ENT, Jinnah Sindh Medical University, Karachi, Pakistan.

Adeel Niaz

Assistant Professor, Department of ENT, Ameer ud Din Medical college, Post Graduate Medical Institute, Lahore, Pakistan.

Waqas Javaid

Assistant Professor of ENT Fatima Jinnah Medical University/Ganga Ram hospital, Lahore, Pakistan.

Publication History

Received: January 02, 2024

Revised: February 12, 2024

Accepted: March 10, 2024

Published: March 15, 2024


Abstract


Background and Objective: A concerning increase in occurrences of COVID-19-associated mucormycosis (CAM), has been reported worldwide in people who are coping with COVID-19 disease. Despite this apparent correlation, the exact association is yet unknown. To ascertain the degree to which mucormycosis and coronavirus illnesses are associated, this study was conducted to analyze the relationship between COVID-19 and mucormycosis infection.
Methods: This observational study examined 35 individuals who had been diagnosed with mucormycosis at Lahore General Hospital, Lahore, Pakistan. The relationship between mucormycosis and coronavirus disease was determined by analyzing the patient’s demographics, gender, COVID-19 status, and co-morbidities.
Results: The mean age of the enrolled patients was 49.40 ± 13.511 years with the majority (54.3%) being male. A total of 25.7% had confirmed COVID-19-positive disease. Notably, diabetes mellitus (DM) was the predominant co-morbidity in a significant proportion of patients (74.3%), followed by comorbidity of DM with chronic kidney disease (11.4%), chronic liver disease (8.6%), and hypertension (5.7%). The presence of co-morbidities and COVID-19 were significantly correlated (p < 0.05) in mucormycosis patients, whereas age and gender had no significant association (p > 0.05).
Conclusion: In conclusion, mucormycosis could be an additional aspect of the pandemic’s spectrum. The data from our study supports this claim since a significant percentage of the patients with mucormycosis had a positive COVID-19 disease concomitantly.


Keywords: COVID-19, Mucormycosis, Diabetes Mellitus, Pandemic, Comorbidities


Pubmed Style

Muhammad Ilyas, Ghulam Dastgir Khan, Ghazala Rubi, Hurtamina Khan, Adeel Niaz, Waqas Javaid. Is Mucormycosis an Addition to the Pandemic Spectrum: An Observational Study. BioMedica. 2024; 15 (March 2024): 32-36. doi:10.24911/BioMedica/5-1148

Web Style

Muhammad Ilyas, Ghulam Dastgir Khan, Ghazala Rubi, Hurtamina Khan, Adeel Niaz, Waqas Javaid. Is Mucormycosis an Addition to the Pandemic Spectrum: An Observational Study. https://biomedicapk.com/articles/online_first/1148 [Access: April 29, 2024]. doi:10.24911/BioMedica/5-1148

AMA (American Medical Association) Style

Muhammad Ilyas, Ghulam Dastgir Khan, Ghazala Rubi, Hurtamina Khan, Adeel Niaz, Waqas Javaid. Is Mucormycosis an Addition to the Pandemic Spectrum: An Observational Study. BioMedica. 2024; 15 (March 2024): 32-36. doi:10.24911/BioMedica/5-1148

Vancouver/ICMJE Style

Muhammad Ilyas, Ghulam Dastgir Khan, Ghazala Rubi, Hurtamina Khan, Adeel Niaz, Waqas Javaid. Is Mucormycosis an Addition to the Pandemic Spectrum: An Observational Study. BioMedica. (2024), [cited April 29, 2024]; 15 (March 2024): 32-36. doi:10.24911/BioMedica/5-1148

Harvard Style

Muhammad Ilyas, Ghulam Dastgir Khan, Ghazala Rubi, Hurtamina Khan, Adeel Niaz, Waqas Javaid (2024) Is Mucormycosis an Addition to the Pandemic Spectrum: An Observational Study. BioMedica, 15 (March 2024): 32-36. doi:10.24911/BioMedica/5-1148

Chicago Style

Muhammad Ilyas, Ghulam Dastgir Khan, Ghazala Rubi, Hurtamina Khan, Adeel Niaz, Waqas Javaid. "Is Mucormycosis an Addition to the Pandemic Spectrum: An Observational Study." 15 (2024), 32-36. doi:10.24911/BioMedica/5-1148

MLA (The Modern Language Association) Style

Muhammad Ilyas, Ghulam Dastgir Khan, Ghazala Rubi, Hurtamina Khan, Adeel Niaz, Waqas Javaid. "Is Mucormycosis an Addition to the Pandemic Spectrum: An Observational Study." 15.March 2024 (2024), 32-36. Print. doi:10.24911/BioMedica/5-1148

APA (American Psychological Association) Style

Muhammad Ilyas, Ghulam Dastgir Khan, Ghazala Rubi, Hurtamina Khan, Adeel Niaz, Waqas Javaid (2024) Is Mucormycosis an Addition to the Pandemic Spectrum: An Observational Study. , 15 (March 2024), 32-36. doi:10.24911/BioMedica/5-1148